Vianda
Vianda has 13 on-market SKUs in the DSLD, first entered 2018-04-25. 76.9% of its products declare at least one proprietary blend, and 35.0% of all its all-time SKUs are now off-market.
13
on-market SKUs
76.9%
with a blend
0.0%
gummies
35.0%
off-market churn
Report card
- Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): 0.5
- % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 76.9%
- Average excipient count per product: 4.6
- First entry: 2018-04-25 · Latest entry: 2021-07-27
- Mineral/vitamin rows by quality tier: tier 1: 58.2%, tier 2: 21.8%, tier 3: 9.1%, unrated: 10.9%
Products (20)
| Product | Form | Status |
|---|---|---|
| Altovis | Capsule | off-market |
| Avlimil | Capsule | off-market |
| Enzyte | Capsule | off-market |
| Enzyte E3 Triple Intensity | Tablet or Pill | off-market |
| Enzyte MRC | Capsule | off-market |
| Ogoplex Extract Pur | Tablet or Pill | off-market |
| Sorbera | Capsule | off-market |
| AliClear | Capsule | on-market |
| Altovis | Capsule | on-market |
| Avlimil | Capsule | on-market |
| Avlimil Multi | Capsule | on-market |
| Enzyte | Capsule | on-market |
| Enzyte E3 Triple Intensity | Tablet or Pill | on-market |
| Enzyte MRC | Capsule | on-market |
| Ogoplex Extract Pur | Tablet or Pill | on-market |
| Pavaxin | Tablet or Pill | on-market |
| Rudofil | Capsule | on-market |
| Sorbera | Capsule | on-market |
| Suvaril | Capsule | on-market |
| Vivora | Softgel Capsule | on-market |